Pelthos Therapeutics PTHS
NYSE PTHS
$20.45 +0.19 (+0.94%)
As of: Oct 20, 2026 · 3:52 PM EDT

Pelthos Therapeutics (PTHS) Work In Process (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported Work In Process of $11.81 million for Q2 2026, down 15.9% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Work In Process (2025 - 2026) Analysis & Trends

At the end of FY2025, Pelthos Therapeutics posted Work In Process of $16.56 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Pelthos Therapeutics 72.38 Mn -16.01 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.81 Mn
Mar 31, 2026 14.04 Mn
Dec 31, 2025 16.56 Mn
API Access

Pelthos Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=PTHS&period=max&api_key=YOUR_API_KEY